Tyler Dost

Company: Pace Analytical

Job title: Account Executive

Seminars:

Targeting PCSK9: The Journey of VXX-401, a Promising New Therapy for Hypercholesterolemia, from Lab to Pilot Production 11:15 am

Formulation Innovation: Explore a case study into the formulation strategies employed by Vaxxinity and Pace® Life Sciences to develop VXX-401, a synthetic peptide vaccine currently in Phase I clinical studies Learn about the advantages of particulate suspensions Challenges in scaling from the research lab to pilot manufacturing Aseptic formulation and filling: benefit from the shared…Read more

day: Day One